Article
GG-NER's role in androgen receptor signaling inhibitor response for advanced prostate cancer.
Cell communication and signaling : CCS - 18 Dec 2024
Zhong Chuanfan, Wang Jiaxing, Peng Hangyang, Lu Jianming, Long Zining, Lin Zhuoyuan, Chen Guo, Cai Chao, Cheng Shilong, Chen Zhongjie, Zhang Le, Zhong Weibo, Mo Rujun, Mao Xiangming
Abstract excerpt
BACKGROUND: Advanced prostate cancer (PCa) often initially responds to androgen receptor signaling inhibitors (ARSI) but frequently develops resistance, driven by tumor heterogeneity and therapeutic pressure. Addressing the clinical challenge of identifying non-responsive patients and discovering new therapeutic targets is urgently needed. METHODS: We utilized single-sample gene set enrichment analysis (ssGSEA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
